SCHEMBL8310682

SCHEMBL8310682

O=C(NC1CCCC1)c1ccc(Cl)s1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.70
SMN1; SMN2 Q16637 6/20 0.70
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
GAA P10253 1/20 0.70
HTT P42858 1/20 0.70
HPGD P15428 4/20 0.67
ALDH1A1 P00352 2/20 0.67
NPC1 O15118 4/20 0.60
TSHR P16473 2/20 0.60
TP53 P04637 2/20 0.60
ESR1 P03372 1/20 0.57
ESRRG P62508 1/20 0.57
ESR2 Q92731 1/20 0.57
PTPN1 P18031 1/20 0.57
PTPN11 Q06124 1/20 0.57
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4658326 0.81 KMT2A (0.50) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL8257466 0.80 SMN1; SMN2 (0.49) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL5436124 0.80 SMN1; SMN2 (0.49) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL12124255 0.80 RAB9A (0.77) RAB9ASMN1; SMN2MEN1KMT2AHPGD
SCHEMBL2203250 0.80 HDAC4 (0.63) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL27537637 0.79 HPGD (0.71) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL12124283 0.79 RAB9A (0.75) RAB9ASMN1; SMN2MEN1KMT2AHPGD
SCHEMBL13461888 0.78 F10 (0.55) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL3448527 0.78 KMT2A (0.58) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL4691317 0.77 F10 (0.54) RAB9ASMN1; SMN2MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed